Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism

American Journal of Reproductive Immunology

Volumn 66, Issue 6, 2011, Pages 527-533

  Lin, Yue Shan ^a,b   Tsai, Shaw Jenq ^c   Lin, Ming Wei ^d   Yang, Cheng Ta ^e   Huang, Mei Feng ^c   Wu, Meng Hsing ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Chronic inflammatory marker; Insulin receptor substrate 2; Interleukin 6; Metformin; Polycystic ovary syndrome; Polymorphism

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TAIWAN;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HOMOZYGOTE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INTERLEUKIN-6; METFORMIN; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; TAIWAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81155131055     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01059.x     Document Type: Article

References (15)

1. Diamanti-Kandarakis E, Paterakis T, Kandarakis HA: Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 2006; 1092:175-186.
2. Chen MJ, Chen HF, Chen SU, Ho HN, Yang YS, Yang WS: The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome. Fertil Steril 2009; 92:2041-2044.
3. Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I, Katsilambros N, Kreatsas G, Panidis D: Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 2006; 21:1426-1431.
4. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R: Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol 2008; 199:596-609.
5. Wu X, Sallinen K, Anttila L, Makinen M, Luo C, Pollanen P, Erkkola R: Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls. Fertil Steril 2000; 74:564-572.
6. Rice S, Pellatt LJ, Bryan SJ, Whitehead SA, Mason HD: Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells. J Clin Endocrinol Metab 2011; 96:E427-E435.
7. Gunton JE, Delhanty PJ, Takahashi S, Baxter RC: Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. J Clin Endocrinol Metab 2003; 88:1323-1332.
8. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-47.
9. Stephens M, Sloan JS, Robertson PD, Scheet P, Nickerson DA: Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat Genet 2006; 38:375-381.
10. Srikanthan P, Korenman S, Davis S: Polycystic ovarian syndrome: the next cardiovascular dilemma in women? Endocrinol Metab Clin North Am 2006; 35:611-631.
11. Samy N, Hashim M, Sayed M, Said M: Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009; 26:163-170.
12. Benson S, Janssen OE, Hahn S, Tan S, Dietz T, Mann K, Pleger K, Schedlowski M, Arck PC, Elsenbruch S: Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun 2008; 22:177-184.
13. Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, Diamanti-Kandarakis E, Panidis D, Creatsas G: Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol 2010; 26:698-703.
14. Villuendas G, Botella-Carretero JI, Roldan B, Sancho J, Escobar-Morreale HF, San Millan JL: Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls. Hum Reprod 2005; 20:3184-3191.
15. Luque-Ramirez M, Escobar-Morreale HF: Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations. Horm Metab Res 2010; 42:815-820.